One year in review 2020: novelties in the treatment of rheumatoid arthritis
Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …
recommendations help in refining the relevant place of different disease-modifying anti …
One year in review 2019: novelties in the treatment of rheumatoid arthritis
E Silvagni, M Di Battista, A Bonifacio… - Clinical and …, 2019 - boa.unimib.it
The current treatment approach in rheumatoid arthritis (RA) follows a stepwise management,
starting from early introduction of conventional synthetic (cs) disease-modifying anti …
starting from early introduction of conventional synthetic (cs) disease-modifying anti …
One year in review 2018: novelties in the treatment of rheumatoid arthritis
The current approach to treatment of rheumatoid arthritis (RA) includes early and aggressive
intervention aiming to reach early and persistent low disease activity and remission. New …
intervention aiming to reach early and persistent low disease activity and remission. New …
One year in review 2021: novelties in the treatment of rheumatoid arthritis
Management of rheumatoid arthritis (RA) has evolved over the years as a result of better
understanding of the role of different therapeutic strategies, as well as following an …
understanding of the role of different therapeutic strategies, as well as following an …
[PDF][PDF] One year in review 2017: novelties in the treatment of rheumatoid arthritis
F Ferro, E Elefante, N Luciano, R Talarico… - Clin Exp …, 2017 - clinexprheumatol.org
Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial
tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to …
tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to …
[PDF][PDF] One year in review 2016: novelties in the treatment of rheumatoid arthritis
A Calabrò, AL Caterino, E Elefante… - Clin Exp …, 2016 - clinexprheumatol.org
Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial
tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to …
tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to …
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for …
A Kerschbaumer, A Sepriano, JS Smolen… - Annals of the …, 2020 - ard.bmj.com
Objectives To inform the 2019 update of the European League against Rheumatism
(EULAR) recommendations for the management of rheumatoid arthritis (RA). Methods A …
(EULAR) recommendations for the management of rheumatoid arthritis (RA). Methods A …
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS …
Objective Longitudinal clinical registry-infrastructures such as Anti-Rheumatic Therapies in
Sweden (ARTIS) allow simultaneous comparison of the safety of individual …
Sweden (ARTIS) allow simultaneous comparison of the safety of individual …
Understanding emerging treatment paradigms in rheumatoid arthritis
FC Breedveld, B Combe - Arthritis Research & Therapy, 2011 - Springer
Abstract Treatment strategies for rheumatoid arthritis (RA) will continue to evolve as new
drugs are developed, as new data become available, and as our potential to achieve greater …
drugs are developed, as new data become available, and as our potential to achieve greater …